# Unicycive Therapeutics, Inc.: Form DEF 14A, filed Apr 30, 2025

- Company: [Unicycive Therapeutics, Inc.](/companies/uncy.md) (CIK 1766140)
- Form: DEF 14A
- Filed: 2025-04-30
- Accepted by EDGAR: Apr 30, 2025, 16:06 ET
- Period: 2025-06-09
- Accession: 0001213900-25-037613
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1766140/000121390025037613/ea0239611-def14a_unicycive.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1766140/000121390025037613/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1766140/000121390025037613/ea0239611-def14a_unicycive.htm

Filed Apr 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-037613. Last ingested by Listed: Oct 29, 2026, 16:30 ET. No prices; not investment advice.